EMWA Symposia

Details of all EMWA symposia are given below. Presentations from the last 3 symposia are available to EMWA members by clicking on the links.



EMWA'S SIXTH ONE-DAY SYMPOSIUM MAY 2018.

Medical Devices and Technologies - Emerging Opportunities for Medical Writers

The sixth EMWA one-day symposium focused on medical devices and the recent changes in the European legislation, targeting regulatory writers and medical communicators alike. It provided the perspectives of different stakeholders, including medical writers, legislators, notified bodies, medical device companies, patient representatives, and reimbursement professionals.


EMWA members can view presentations that were made at this event by clicking on the links below.

PDF IconClaudia Frumento - EMWA Symposium 2018

PDF Icon Gillian Pritchard - EMWA Symposium 2018

PDF Icon Ivan Krstic - EMWA Symposium 2018

PDF Icon Oleg Borisenko - EMWA Symposium 2018

PDF IconPaul Piscoi - EMWA Symposium 2018



EMWA's Fifth One-Day Symposium May 2017.

Transparency and Disclosure of Clinical Regulatory Documentation

The fifth EMWA one-day symposium focused on the rapidly changing field of regulatory public disclosure requirements and how these changes impact the consumers, the writers, and how information is disclosed. Through the onset of regulatory public disclosure, the importance of “smart writing” – and thus of the medical writer role - has become paramount. Regulatory public disclosure imposes new demands on information presentation in documents, terminologies, document structure, and consistency. There are also overlaps with disclosure aspects in pharmacovigilance.

EMWA members can view presentations that were made at this event by clicking on the links below.

PDF Icon Disclosure of Clinical Regulatory Documentation The (IQWiG) User Perspective

PDF Icon Disclosure of Clinical Regulatory Documentation - The Medical Writer Perspective

PDF Icon Update on EU Transparency in clinical trials

PDF Icon Clinical Trial Disclosure - Status Update - Regulation 536/2014

PDF Icon CORE Reference - One Year On




EMWA's Third One-Day Symposium May 2015.

RISK MANAGEMENT AND RISK-BENEFIT EVALUATION-A 360 DEGREE PERSPECTIVE

This successful Symposium was moderated by Tiziana von Bruchhausen and Rohit Pushparajan, who welcomed representatives of European Medicines Agency, patient advocate groups, medical writers and different pharmaceutical companies.

EMWA members can view presentations that were made at this event by clicking on the links below.

PDF Icon Overview of risk-benefit evaluation – Art Gertel

PDF Icon The European Medicines Agency perspective – Juan Garcia

PDF Icon Medical writer’s perspective – Sven Schirp

PDF Icon Industry perspective – Peter Verdru

PDF Icon Patient perspective – Erik Briers

PDF Icon Patient perspective – David Gilbert